Table 2.
Comparison of survival for recurrence from CRC treated by surgery or other treatment method
| Study | Failure site | Treatment | n | Median survival (mo) | Survival rate (yr) |
| Gwin et al[15], 1993 | Non-hepatic intra-abdominal | R01 | 15 | 25.5 | 60 (2), 0 (3) |
| R12 | 6 | 8 | 34 (2), 34 (3) | ||
| R23 | 7 | 3.5 | 15 (2) | ||
| Shibata et al[13], 2002 | Retroperitoneum | R0 | 15 | 81 | 56 (5) |
| R1 | 5 | 29 | 0 (5) | ||
| R2 | 4 | 3 | 0 (5) | ||
| Bowne et al[14], 2005 | Retroperitoneum | R0 | 8 | 44 | NA |
| R1 | 8 | ||||
| Min et al[12], 2008 | PALN | R0 | 6 | 34 | 80 (3), 0 (5) |
| Chemotherapy4 | 33 | 12 | 18 (3), 7 (5) | ||
| Present study | PALN | SBRT | 7 | 41 | 71.4 (3) |
1
Curative resection;
2
Marginal resection;
3
Incomplete, bypass or colostomy;
4
Resection is not planned. CRC: Colorectal cancer; PALN: Paraaortic lymph node; SBRT: Stereotactic body radiotherapy; NA: Not assessed.